Michael F. MacLean - 17 Jun 2021 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
Director
Signature
/s/ Andrew Ashe, Attorney-in-Fact For Michael MacLean
Issuer symbol
VERV
Transactions as of
17 Jun 2021
Transactions value $
$0
Form type
4
Filing time
21 Jun 2021, 18:21:47
Previous filing
16 Jun 2021
Next filing
15 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERV Stock Option (right to buy) Award $0 +47.7K $0.00 47.7K 17 Jun 2021 Common Stock 47.7K $19.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on June 17, 2021. The shares underlying the option vest quarterly over four years in 16 equal installments following May 20, 2021.